Arcus Biosciences (RCUS) Assets Growth (3y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Arcus Biosciences | 3.18 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.36% |
| Dec 31, 2025 | -4.31% |
| Sep 30, 2025 | -11.26% |
| Jun 30, 2025 | -10.04% |
| Mar 31, 2025 | -8.05% |
| Dec 31, 2024 | -10.27% |
| Sep 30, 2024 | 15.70% |
| Jun 30, 2024 | 10.11% |
| Mar 31, 2024 | 11.61% |
| Dec 31, 2023 | 12.34% |
| Sep 30, 2023 | 13.66% |
| Jun 30, 2023 | 36.34% |
| Mar 31, 2023 | 92.37% |
| Dec 31, 2022 | 85.67% |
| Sep 30, 2022 | 85.90% |
| Jun 30, 2022 | 83.51% |
| Mar 31, 2022 | 81.41% |
| Dec 31, 2021 | 79.57% |
| Sep 30, 2021 | 43.05% |
| Jun 30, 2021 | 45.16% |
| Mar 31, 2021 | 45.21% |
| Dec 31, 2020 | 59.46% |